Search research articles
Contact Us
Filters
Showing results (21-30 of 71) with videos related to
Page
of 8
Sort By:
Gastroenterologia Y Hepatologia
|
January 11, 2020
Impact of perioperative transfusions and sepsis on long-term oncologic outcomes after curative colon cancer resection. A retrospective analysis of a prospective database
Gloria Baguena, Gianluca Pellino, Matteo Frasson, et al.
Clinical & Experimental Metastasis
|
April 25, 2012
Profiling immunohistochemical expression of NOTCH1-3, JAGGED1, cMET, and phospho-MAPK in 100 carcinomas of unknown primary
Dimitrios Krikelis, George Pentheroudakis, Anna Goussia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 1, 2010
Phase I safety, pharmacokinetics, and inhibition of SRC activity study of saracatinib in patients with solid tumors
José Baselga, Andres Cervantes, Erika Martinelli, et al.
The Oncologist
|
March 29, 2014
An open-label phase II study evaluating the safety and efficacy of ramucirumab combined with mFOLFOX-6 as first-line therapy for metastatic colorectal cancer
Rocio Garcia-Carbonero, Fernando Rivera, Joan Maurel, et al.
Anticancer Research
|
April 12, 2012
Immunohistochemical study of the epithelial-mesenchymal transition phenotype in cancer of unknown primary: incidence, correlations and prognostic utility
Aikaterini Stoyianni, Anna Goussia, George Pentheroudakis, et al.
Clinical Colorectal Cancer
|
July 6, 2021
Retrospective Study of Regorafenib Versus TAS-102 Efficacy and Safety in Chemorefractory Metastatic Colorectal Cancer (mCRC) Patients: A Multi-institution Real Life Clinical Data
Pasquale Vitale, Nicoletta Zanaletti, Vincenzo Famiglietti, et al.
British Journal of Cancer
|
July 20, 2023
Pamiparib in combination with tislelizumab in patients with advanced solid tumours: results from the dose-expansion stage of a multicentre, open-label, phase I trial
Michael Friedlander, Linda Mileshkin, Janine Lombard, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
September 13, 2018
Low miR200c expression in tumor budding of invasive front predicts worse survival in patients with localized colon cancer and is related to PD-L1 overexpression
Carolina Martinez-Ciarpaglini, Sara Oltra, Susana Roselló, et al.
Oncotarget
|
December 30, 2017
mRNA expression profiles obtained from microdissected pancreatic cancer cells can predict patient survival
Ana-Barbara García-García, M Carmen Gómez-Mateo, Rebeca Hilario, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 5, 2012
Multicenter randomized phase II clinical trial comparing neoadjuvant oxaliplatin, capecitabine, and preoperative radiotherapy with or without cetuximab followed by total mesorectal excision in patients with high-risk rectal cancer (EXPERT-C)
Alice Dewdney, David Cunningham, Josep Tabernero, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 71) with videos related to
Sort By:
Page
of 8
Gastroenterologia Y Hepatologia
|
January 11, 2020
Impact of perioperative transfusions and sepsis on long-term oncologic outcomes after curative colon cancer resection. A retrospective analysis of a prospective database
Gloria Baguena, Gianluca Pellino, Matteo Frasson, et al.
Clinical & Experimental Metastasis
|
April 25, 2012
Profiling immunohistochemical expression of NOTCH1-3, JAGGED1, cMET, and phospho-MAPK in 100 carcinomas of unknown primary
Dimitrios Krikelis, George Pentheroudakis, Anna Goussia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 1, 2010
Phase I safety, pharmacokinetics, and inhibition of SRC activity study of saracatinib in patients with solid tumors
José Baselga, Andres Cervantes, Erika Martinelli, et al.
The Oncologist
|
March 29, 2014
An open-label phase II study evaluating the safety and efficacy of ramucirumab combined with mFOLFOX-6 as first-line therapy for metastatic colorectal cancer
Rocio Garcia-Carbonero, Fernando Rivera, Joan Maurel, et al.
Anticancer Research
|
April 12, 2012
Immunohistochemical study of the epithelial-mesenchymal transition phenotype in cancer of unknown primary: incidence, correlations and prognostic utility
Aikaterini Stoyianni, Anna Goussia, George Pentheroudakis, et al.
Clinical Colorectal Cancer
|
July 6, 2021
Retrospective Study of Regorafenib Versus TAS-102 Efficacy and Safety in Chemorefractory Metastatic Colorectal Cancer (mCRC) Patients: A Multi-institution Real Life Clinical Data
Pasquale Vitale, Nicoletta Zanaletti, Vincenzo Famiglietti, et al.
British Journal of Cancer
|
July 20, 2023
Pamiparib in combination with tislelizumab in patients with advanced solid tumours: results from the dose-expansion stage of a multicentre, open-label, phase I trial
Michael Friedlander, Linda Mileshkin, Janine Lombard, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
September 13, 2018
Low miR200c expression in tumor budding of invasive front predicts worse survival in patients with localized colon cancer and is related to PD-L1 overexpression
Carolina Martinez-Ciarpaglini, Sara Oltra, Susana Roselló, et al.
Oncotarget
|
December 30, 2017
mRNA expression profiles obtained from microdissected pancreatic cancer cells can predict patient survival
Ana-Barbara García-García, M Carmen Gómez-Mateo, Rebeca Hilario, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 5, 2012
Multicenter randomized phase II clinical trial comparing neoadjuvant oxaliplatin, capecitabine, and preoperative radiotherapy with or without cetuximab followed by total mesorectal excision in patients with high-risk rectal cancer (EXPERT-C)
Alice Dewdney, David Cunningham, Josep Tabernero, et al.
Page
of 8